Reading “DMT2” in a patient’s chart: “diabetes mellitus type 2”
Reading “T2DM” in a patient’s chart: “Terminator 2 diabetes mellitus”
Reading “T2DM” in a patient’s chart: “Terminator 2 diabetes mellitus”
January 29, 2025 at 5:19 PM
Reading “DMT2” in a patient’s chart: “diabetes mellitus type 2”
Reading “T2DM” in a patient’s chart: “Terminator 2 diabetes mellitus”
Reading “T2DM” in a patient’s chart: “Terminator 2 diabetes mellitus”
Let's make this day a day of happiness and friendship.
music.youtube.com/watch?v=Dmt2...
music.youtube.com/watch?v=Dmt2...
Universe of Time
YouTube video by Allen Anderson - Topic
music.youtube.com
March 3, 2026 at 4:44 PM
Let's make this day a day of happiness and friendship.
music.youtube.com/watch?v=Dmt2...
music.youtube.com/watch?v=Dmt2...
10/10
Final #nephjc thoughts
BPROAD demonstrated that intensive BP lowering (SBP<120) in pts with DMT2 significantly reduced MACE, primarily driven by reduced stroke events.
But... 🤔 Targets vs. Tenets 🤔
@mikejohansenmd.bsky.social
@hswapnil.bsky.social
Final #nephjc thoughts
BPROAD demonstrated that intensive BP lowering (SBP<120) in pts with DMT2 significantly reduced MACE, primarily driven by reduced stroke events.
But... 🤔 Targets vs. Tenets 🤔
@mikejohansenmd.bsky.social
@hswapnil.bsky.social
December 16, 2024 at 7:39 PM
10/10
Final #nephjc thoughts
BPROAD demonstrated that intensive BP lowering (SBP<120) in pts with DMT2 significantly reduced MACE, primarily driven by reduced stroke events.
But... 🤔 Targets vs. Tenets 🤔
@mikejohansenmd.bsky.social
@hswapnil.bsky.social
Final #nephjc thoughts
BPROAD demonstrated that intensive BP lowering (SBP<120) in pts with DMT2 significantly reduced MACE, primarily driven by reduced stroke events.
But... 🤔 Targets vs. Tenets 🤔
@mikejohansenmd.bsky.social
@hswapnil.bsky.social
A signal of protection from myeloid neoplasms by GLP-1RA - Shernan Holtan
@sghmd.bsky.social
oncodaily.com/science/sher...
#Cancer #CancerResearch #GLP1RA #MyeloidNeoplasm #BloodCancer #DMT2 #Medicine #Health #Oncology #OncoDaily
@sghmd.bsky.social
oncodaily.com/science/sher...
#Cancer #CancerResearch #GLP1RA #MyeloidNeoplasm #BloodCancer #DMT2 #Medicine #Health #Oncology #OncoDaily
Shernan Holtan: A signal of protection from myeloid neoplasms by GLP-1RA - OncoDaily
Shernan Holtan: A signal of protection from myeloid neoplasms by GLP-1RA / Abhay Singh, Ali Mushtaq, cancer, David Kaelber, Faiz Anwer, GLP-1 Receptor
oncodaily.com
March 15, 2025 at 9:10 PM
A signal of protection from myeloid neoplasms by GLP-1RA - Shernan Holtan
@sghmd.bsky.social
oncodaily.com/science/sher...
#Cancer #CancerResearch #GLP1RA #MyeloidNeoplasm #BloodCancer #DMT2 #Medicine #Health #Oncology #OncoDaily
@sghmd.bsky.social
oncodaily.com/science/sher...
#Cancer #CancerResearch #GLP1RA #MyeloidNeoplasm #BloodCancer #DMT2 #Medicine #Health #Oncology #OncoDaily
Yeah Anthony Allen Russell
2327 Wilsey Redding, CA
Malignant narcissist sociopath with stage four neuroendocrine prostate carcinoma cured, diagnosed 2007, bone samples sent to NIH in 12/2017, DMT2 with neuropathy LOPS BK s/p T/S bone vertebrae rongeur @ T5 for potential CA metabolite I treated him
2327 Wilsey Redding, CA
Malignant narcissist sociopath with stage four neuroendocrine prostate carcinoma cured, diagnosed 2007, bone samples sent to NIH in 12/2017, DMT2 with neuropathy LOPS BK s/p T/S bone vertebrae rongeur @ T5 for potential CA metabolite I treated him
June 5, 2025 at 9:50 PM
Yeah Anthony Allen Russell
2327 Wilsey Redding, CA
Malignant narcissist sociopath with stage four neuroendocrine prostate carcinoma cured, diagnosed 2007, bone samples sent to NIH in 12/2017, DMT2 with neuropathy LOPS BK s/p T/S bone vertebrae rongeur @ T5 for potential CA metabolite I treated him
2327 Wilsey Redding, CA
Malignant narcissist sociopath with stage four neuroendocrine prostate carcinoma cured, diagnosed 2007, bone samples sent to NIH in 12/2017, DMT2 with neuropathy LOPS BK s/p T/S bone vertebrae rongeur @ T5 for potential CA metabolite I treated him
Happy #FLOW trial publication day to all who celebrate 🎉
Effects of Semaglutide on CKD in Pts w/ DMT2 @NEJM
Reduction in:
Primary composite kidney outcomes 🥊
GFR slope 🥊
CV Death 🥊
All cause death 🥊
@hswapnil.bsky.social #ERA24 #NephSky www.nejm.org/doi/full/10....
Effects of Semaglutide on CKD in Pts w/ DMT2 @NEJM
Reduction in:
Primary composite kidney outcomes 🥊
GFR slope 🥊
CV Death 🥊
All cause death 🥊
@hswapnil.bsky.social #ERA24 #NephSky www.nejm.org/doi/full/10....
Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes | NEJM
Patients with type 2 diabetes and chronic kidney disease are at high risk for kidney
failure, cardiovascular events, and death. Whether treatment with semaglutide would
mitigate these risks is unkn...
www.nejm.org
May 24, 2024 at 8:28 PM
Happy #FLOW trial publication day to all who celebrate 🎉
Effects of Semaglutide on CKD in Pts w/ DMT2 @NEJM
Reduction in:
Primary composite kidney outcomes 🥊
GFR slope 🥊
CV Death 🥊
All cause death 🥊
@hswapnil.bsky.social #ERA24 #NephSky www.nejm.org/doi/full/10....
Effects of Semaglutide on CKD in Pts w/ DMT2 @NEJM
Reduction in:
Primary composite kidney outcomes 🥊
GFR slope 🥊
CV Death 🥊
All cause death 🥊
@hswapnil.bsky.social #ERA24 #NephSky www.nejm.org/doi/full/10....
2/10
What'd I miss?
❗ 2022 EMPA-KIDNEY (pmid 39453837) showed #empagliflozin significantly reduced risk of progression of kidney dz & CV death in pts +/- DMT2 (mean f/u 2 yr, trial stopped early)
❓ But… THEN what happened?
🗓️ Post-trial follow-up for an additional 2️⃣ years 👇👇
What'd I miss?
❗ 2022 EMPA-KIDNEY (pmid 39453837) showed #empagliflozin significantly reduced risk of progression of kidney dz & CV death in pts +/- DMT2 (mean f/u 2 yr, trial stopped early)
❓ But… THEN what happened?
🗓️ Post-trial follow-up for an additional 2️⃣ years 👇👇
November 11, 2024 at 5:20 PM
2/10
What'd I miss?
❗ 2022 EMPA-KIDNEY (pmid 39453837) showed #empagliflozin significantly reduced risk of progression of kidney dz & CV death in pts +/- DMT2 (mean f/u 2 yr, trial stopped early)
❓ But… THEN what happened?
🗓️ Post-trial follow-up for an additional 2️⃣ years 👇👇
What'd I miss?
❗ 2022 EMPA-KIDNEY (pmid 39453837) showed #empagliflozin significantly reduced risk of progression of kidney dz & CV death in pts +/- DMT2 (mean f/u 2 yr, trial stopped early)
❓ But… THEN what happened?
🗓️ Post-trial follow-up for an additional 2️⃣ years 👇👇
Very old Apple commercial with Kerry Shale. youtu.be/TXMxXjoMjyA?... ❤️❤️❤️
They should have used his voice.
They should have used his voice.
Apple Macintosh Advert 1985 (UK)
YouTube video by dmt2
youtu.be
January 25, 2025 at 9:02 PM
Very old Apple commercial with Kerry Shale. youtu.be/TXMxXjoMjyA?... ❤️❤️❤️
They should have used his voice.
They should have used his voice.